Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.

Literature DB >> 21358716

Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.

J N Berman, R B Gerbing, T A Alonzo, P A Ho, K Miller, C Hurwitz, N A Heerema, B Hirsch, S C Raimondi, B Lange, J L Franklin, A Gamis, S Meshinchi.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2011 PMID： 21358716 PMCID： PMC4504732 DOI： 10.1038/leu.2011.31

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

21 in total

Review 1. Genetics of myeloid malignancies: pathogenetic and clinical implications.

Authors: Stefan Fröhling; Claudia Scholl; D Gary Gilliland; Ross L Levine
Journal: J Clin Oncol Date: 2005-09-10 Impact factor: 44.544

2. Implications of NRAS mutations in AML: a study of 2502 patients.

Authors: Ulrike Bacher; Torsten Haferlach; Claudia Schoch; Wolfgang Kern; Susanne Schnittger
Journal: Blood Date: 2006-01-24 Impact factor: 22.113

3. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.

Authors: T Nakagawa; S Saitoh; S Imoto; M Itoh; M Tsutsumi; K Hikiji; H Nakamura; S Matozaki; R Ogawa; Y Nakao
Journal: Oncology Date: 1992 Impact factor: 2.935

4. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors: J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal: Ann Intern Med Date: 1985-10 Impact factor: 25.391

5. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Authors: Christian Thiede; Christine Steudel; Brigitte Mohr; Markus Schaich; Ulrike Schäkel; Uwe Platzbecker; Martin Wermke; Martin Bornhäuser; Markus Ritter; Andreas Neubauer; Gerhard Ehninger; Thomas Illmer
Journal: Blood Date: 2002-06-15 Impact factor: 22.113

6. Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

Authors: N Boissel; H Leroy; B Brethon; N Philippe; S de Botton; A Auvrignon; E Raffoux; T Leblanc; X Thomas; O Hermine; B Quesnel; A Baruchel; G Leverger; H Dombret; C Preudhomme
Journal: Leukemia Date: 2006-06 Impact factor: 11.528

7. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.

Authors: M Lübbert; J Mirro; G Kitchingman; F McCormick; R Mertelsmann; F Herrmann; H P Koeffler
Journal: Oncogene Date: 1992-02 Impact factor: 9.867

8. Significance of chromosomal alterations and mutations of the N-RAS and TP53 genes in relation to leukemogenesis of acute myeloid leukemia.

Authors: S Misawa; S Horiike; H Kaneko; Y Sasai; Y Ueda; M Nakao; S Yokota; M Taniwaki; H Fujii; H Nakagawa; S Tsuda; K Kashima
Journal: Leuk Res Date: 1998-07 Impact factor: 3.156

9. Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemic progression from myelodysplastic syndrome.

Authors: H Hirai; M Okada; H Mizoguchi; H Mano; Y Kobayashi; J Nishida; F Takaku
Journal: Blood Date: 1988-01 Impact factor: 22.113

10. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.

Authors: H Hirai; Y Kobayashi; H Mano; K Hagiwara; Y Maru; M Omine; H Mizoguchi; J Nishida; F Takaku
Journal: Nature Date: 1987 Jun 4-10 Impact factor: 49.962

18 in total

Review 1. Targeting oncogenic Ras signaling in hematologic malignancies.

Authors: Ashley F Ward; Benjamin S Braun; Kevin M Shannon
Journal: Blood Date: 2012-08-16 Impact factor: 22.113

2. Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.

Authors: Marijana Vujkovic; Edward F Attiyeh; Rhonda E Ries; Elizabeth K Goodman; Yang Ding; Marko Kavcic; Todd A Alonzo; Yi-Cheng Wang; Robert B Gerbing; Lillian Sung; Betsy Hirsch; Susana Raimondi; Alan S Gamis; Soheil Meshinchi; Richard Aplenc
Journal: Blood Date: 2017-04-14 Impact factor: 22.113

Review 3. Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia.

Authors: Alan S Gamis; Todd A Alonzo; John P Perentesis; Soheil Meshinchi
Journal: Pediatr Blood Cancer Date: 2012-12-19 Impact factor: 3.167

4. Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group.

Authors: Roland B Walter; George S Laszlo; Todd A Alonzo; Robert B Gerbing; Shawn Levy; Matthew P Fitzgibbon; Chelsea J Gudgeon; Rhonda E Ries; Kimberly H Harrington; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Martin W McIntosh; Soheil Meshinchi
Journal: Am J Hematol Date: 2013-06-20 Impact factor: 10.047

5. Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group.

Authors: Norman J Lacayo; Todd A Alonzo; Urte Gayko; David B Rosen; Matt Westfall; Norman Purvis; Santosh Putta; Brent Louie; James Hackett; Aileen Cleary Cohen; Alessandra Cesano; Robert Gerbing; Yaddanapudi Ravindranath; Gary V Dahl; Alan Gamis; Soheil Meshinchi
Journal: Br J Haematol Date: 2013-05-20 Impact factor: 6.998

Review 6. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.

Authors: C Michel Zwaan; Edward A Kolb; Dirk Reinhardt; Jonas Abrahamsson; Souichi Adachi; Richard Aplenc; Eveline S J M De Bont; Barbara De Moerloose; Michael Dworzak; Brenda E S Gibson; Henrik Hasle; Guy Leverger; Franco Locatelli; Christine Ragu; Raul C Ribeiro; Carmelo Rizzari; Jeffrey E Rubnitz; Owen P Smith; Lillian Sung; Daisuke Tomizawa; Marry M van den Heuvel-Eibrink; Ursula Creutzig; Gertjan J L Kaspers
Journal: J Clin Oncol Date: 2015-08-24 Impact factor: 44.544